The three-vessel occlusion as a model of vascular dementia - Oxidative stress and mitochondrial failure as an indicator of brain hypoperfusion

Systems Biology of Free Radicals and Antioxidants

Volumn , Issue , 2012, Pages 2023-2032

  Aliev, Gjumrakch ^a,b   Horecký, Jaromir ^c   Vančová, Olga ^d   Ashraf, Ghulam Md ^e   Hassan, Iftekhar ^f   Bragin, Valentin ^g   Bragin, Ilya ^h   Shevtsova, Elena ⁱ   Klochkov, Sergey G ⁱ   Kosenko, Elena A ^j   Cacabelos, Ramon ^l   Bachurin, Sergey O ⁱ   Benberin, Valery V ^k   Kaminsky, Yury G ^j  

^a GALLY International Biomedical Research Consulting LLC   (United States)

^b University of Atlanta   (United States)

^c SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^d Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^e KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^f ALIGARH MUSLIM UNIVERSITY   (India)

^g Stress Relief and Memory Training Center   (United States)

^h SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

ⁱ INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

^j INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

^k Medical Center of the Administration of the President of the Republic of Kazakhstan   (Kazakhstan)

^l CAMILO JOSÉ CELA UNIVERSITY   (Spain)

more..

Author keywords

^{31< sup>P NMR NMR; Brain 3 VO hypoperfusion; Creatine kinase; Mitochondria; Oxidative phosphorylation}

Indexed keywords

EID: 84929138301     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-30018-9_205     Document Type: Chapter

References (25)

1. Aliev G, Smith MA, Obrenovich ME et al (2003) Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Alzheimer disease. Neurotox Res 5:491-504
2. Aliev G, Smith MA, de la Torre JC et al (2004) Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion 4:649-663
3. Aliev G, Shenk JC, Fischbach K et al (2008) Stem cell niches as clinical targets: The future of antiischemic therapy? Nat Clin Pract Cardiovasc Med 5(9):590-591
4. Aliev G, Li Y, Palacios HH et al (2011) Oxidative stress induced mitochondrial DNA deletion as a hallmark for the drug development in the context of the cerebrovascular diseases. Recent Pat Cardiovasc Drug Discov 6(3):222-241
5. Bittl JA, De Layre J, Ingwall JS (1987) Rate equation for creatine kinase predicts the in vivo reaction velocity: 31P-NMR surface coil studies in brain, heart and skeletal muscle of the living rat. Biochemistry 26:6083-6090
6. Clark JF, Harris GI, Dillon PF (1991) Multisite saturation transfer using DANTE and continuous wave. Magn Reson Med 17:274-278
7. de la Torre JC (2002) Alzheimer's disease as a vascular disorder: nosological evidence. Stroke 33:1152-1162
8. de la Torre JC (2004) Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 3(3):184-190 Erratum in Lancet Neurol 2004; 3(5):270
9. de la Torre JC, Fortin T (1994) A chronic physiological rat model of dementia. Behav Brain Res 63:35-40
10. Forsen F, Hoffman RA (1963) Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys 39:2892-2901
11. Horecký J, Kašparová S, Vancǒvá O et al (2005) Mitochondrial dysfunction in brain neurodegenerative disorders: ageing and chronic cerebral hypoperfusion. Mitochondrial Physiol Netw 10(9):128-129
12. Horecký J, Bačiak L, Vancǒvá O et al (2006) Effect of transient ischemia on rat brain energy metabolism assessed in vivo by 31P MRS and in vitro by mitochondrial OXPHOS. Biochem Biophys Acta Bioenerg (Suppl S)
13. Horecký J, Baciak L, Kašparová S et al (2009) Minimally invasive surgical approach for threevessel occlusion as a model of vascular dementia in the rat-brain bioenergetics assay. J Neurol Sci 1-2:178-181
14. Horecky J, Gvozdjáková A, Kucharská J et al (2011) Effects of coenzyme Q and creatine supplementation on brain energy metabolism in rats exposed to chronic cerebral hypoperfusion. Curr Alzheimer Res 8(8):868-875
15. Kašparová S, Brezová V, Valko M et al (2005a) Study of the oxidative stress in a rat model of chronic hypoperfusion. Neurochem Int 46:601-611
16. Kašparová S, Zbýň Š, Ž ilka N et al (2005b) 31P magnetic resonance spectroscopy study of brain creatine kinase in rats with moderate and severe hypertension and chronic cerebral hypoperfusion. Biologia 60:81-84
17. Lowry DH, Rosenbrough NY, Farr AL (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-276
18. Meier-Ruge W, Iwangoff P, Bertoni-Freddari C (1994) What is primary and what is secondary for amyloid deposition in Alzheimer's disease. Ann N Y Acad Sci 719:230-237
19. Morris GA, Freeman R (2011) Selective excitation in Fourier transform nuclear magnetic resonance. J Magn Reson 213(2):214-243
20. Palacios HH, Yendluri BB, Parvathaneni K et al (2011) Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease. CNS Neurol Disord Drug Targets 10(2):149-162
21. Sarma JS, Ikeda S, Fischer R et al (1976) Biochemical and contractile properties of heart muscle after prolonged alcohol administration. J Mol Cell Cardiol 8:951-972
22. Schubert D (2005) Glucose metabolism and Alzheimer's disease. Ageing Res Rev 4:240-257
23. Vancǒvá O, Bačiak L, Kašparová S et al (2010) In vivo and in vitro assessment of brain bioenergetics in aging rats. J Cell Mol Med 14(11):2667-2674
24. Zhu X, Raina AK, Lee HG et al (2004a) Oxidative stress signaling in Alzheimer's disease. Brain Res 1000:32-39
25. Zhu X, Smith MA, Perry G et al (2004b) Mitochondrial failures in Alzheimer disease. Am J Alzheimers Dis Other Demen 19:345-352